ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

Cancer Atlast Offers New Research Leads

July 17, 1987

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

Alliteration And Prayer Were Andrew von Eschenbach’s Tools For Making Progress Possible For People.

May 19, 2006

Et2’s Referral Guidelines

July 23, 1993

“The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.”

July 7, 1995